Work

Utidelone plus pembrolizumab as the fourth-line combination treatment in non-small cell lung cancer with EGFR mutation: a case report

Year: 2024

Type: article

Study design: Case Report

Source: Anti-Cancer Drugs

DOI: 10.1097/cad.0000000000001661

Authors: Henghu Fang, Wei Yang, Qing Han, Rugang Zhao, Wei Zheng, Zejun Lu, Shanshan Wu, Qi Zhu, Jingjiao Li, Gaowa Guan, Juyi Wen

Institution: Chinese PLA General Hospital

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4403535903

FWCI: 0.517

Cites: 5

Cited by: 2

Related to: 10